TAF
MRNA icon

Tredje AP-fonden’s Moderna MRNA Stock Holding History

Tredje AP-fonden’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-12,618
Closed -$1.3M – 544
2023
Q3 		$1.3M Hold
12,618
– – 0.02% 449
2023
Q2 		$1.53M Hold
12,618
– – 0.02% 434
2023
Q1 		$1.94M Hold
12,618
– – 0.03% 392
2022
Q4 		$2.27M Buy
12,618
+1,200
+11% +$196K 0.04% 347
2022
Q3 		$1.35M Sell
11,418
-16,667
-59% -$2.53M 0.03% 420
2022
Q2 		$4.01M Hold
28,085
– – 0.1% 166
2022
Q1 		$4.84M Hold
28,085
– – 0.1% 172
2021
Q4 		$7.13M Buy
28,085
+3,085
+12% +$902K 0.14% 134
2021
Q3 		$9.62M Buy
+25,000
New +$9.22M 0.2% 102

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Tredje AP-fonden's MRNA Position: Q4 2023 in Review

Tredje AP-fonden sold out of Moderna (MRNA) in Q4 2023, closing a stake of 12,618 shares — an estimated $1.3M sold.

Tredje AP-fonden first reported a position in MRNA in Q3 2021 and held it in 9 quarters. The position peaked at $9.62M in Q3 2021. 884 funds tracked by Wall St. Rank hold MRNA as of Q4 2023.

  • Tredje AP-fonden reported no remaining Moderna position as of Q4 2023 after selling out during the quarter.
  • Tredje AP-fonden sold 12,618 Moderna shares in Q4 2023, an estimated $1.3M.
  • Tredje AP-fonden first reported a position in Moderna in Q3 2021 and held it in 9 quarters.
  • Tredje AP-fonden's Moderna position peaked at $9.62M in Q3 2021.
  • 884 funds tracked by Wall St. Rank held Moderna as of Q4 2023.

Based on Tredje AP-fonden's 13F filing for Q4 2023, filed 12 Feb 2024.